WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

WEDNESDAY, March 22, 2023 (HealthDay News) — Exercise can help improve movement-related symptoms for people who have Parkinson’s disease, a new review finds. And any type of structured exercise is better than none, researchers added. The findings were published recently in the Cochrane Reviews. “Parkinson’s disease cannot be cured, butContinue Reading

WEDNESDAY, March 8, 2023 (HealthDay News) — Some people may have a gene that helps protect them from respiratory diseases like COVID-19 — and helped their ancestors fight the plague. It comes at a cost. This same gene variation may be linked to an increased risk of autoimmune disease, includingContinue Reading

FRIDAY, Feb. 24, 2023 (HealthDay News) — People living in heavily polluted areas of the United States may be more vulnerable to Parkinson’s disease, a new study suggests. Specifically, the culprit is a type of air pollution called fine particulate matter (PM2.5), which is less than 2.5 microns in diameterContinue Reading

THURSDAY, Feb. 23, 2023 (HealthDay News) — A noninvasive treatment that heats specific areas of brain tissue may ease movement symptoms in some people with Parkinson’s disease, a clinical trial has found. The study tested the effects of an incision-free procedure called focused ultrasound ablation, where doctors use sound wavesContinue Reading